| Symbol |
Name |
|
ABCA4
|
ATP-binding cassette, sub-family A (ABC1), member 4
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADGRE5
|
adhesion G protein-coupled receptor E5
|
|
ADK
|
adenosine kinase
|
|
ADM
|
adrenomedullin
|
|
ADORA2A
|
adenosine A2a receptor
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AHSG
|
alpha-2-HS-glycoprotein
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
|
ANG
|
angiogenin, ribonuclease, RNase A family, 5
|
|
ANXA1
|
annexin A1
|
|
APAF1
|
apoptotic peptidase activating factor 1
|
|
APOC1
|
apolipoprotein C-I
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP1
|
aquaporin 1 (Colton blood group)
|
|
AQP4
|
aquaporin 4
|
|
AR
|
androgen receptor
|
|
ARF6
|
ADP-ribosylation factor 6
|
|
ARHGEF11
|
Rho guanine nucleotide exchange factor (GEF) 11
|
|
ARX
|
aristaless related homeobox
|
|
ATP2A2
|
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
|
|
ATP8B1
|
ATPase, aminophospholipid transporter, class I, type 8B, member 1
|
|
B2M
|
beta-2-microglobulin
|
|
BAG1
|
BCL2-associated athanogene
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRAP
|
BRCA1 associated protein
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRMS1
|
breast cancer metastasis suppressor 1
|
|
BSG
|
basigin (Ok blood group)
|
|
C3
|
complement component 3
|
|
C4B
|
complement component 4B (Chido blood group)
|
|
C9ORF72
|
chromosome 9 open reading frame 72
|
|
CACNA1A
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CAT
|
catalase
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR3
|
chemokine (C-C motif) receptor 3
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR6
|
chemokine (C-C motif) receptor 6
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD151
|
CD151 molecule (Raph blood group)
|
|
CD177
|
CD177 molecule
|
|
CD24
|
CD24 molecule
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CDHR5
|
cadherin-related family member 5
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CHAD
|
chondroadherin
|
|
CHGA
|
chromogranin A
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
|
CLEC7A
|
C-type lectin domain family 7, member A
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRYAA
|
crystallin, alpha A
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CST3
|
cystatin C
|
|
CTGF
|
connective tissue growth factor
|
|
CTSB
|
cathepsin B
|
|
CTTN
|
cortactin
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
DIO2
|
deiodinase, iodothyronine, type II
|
|
DIO3
|
deiodinase, iodothyronine, type III
|
|
DMPK
|
dystrophia myotonica-protein kinase
|
|
DRD1
|
dopamine receptor D1
|
|
DRD2
|
dopamine receptor D2
|
|
DRD3
|
dopamine receptor D3
|
|
DRD4
|
dopamine receptor D4
|
|
DYSF
|
dysferlin
|
|
EBAG9
|
estrogen receptor binding site associated, antigen, 9
|
|
ECT2
|
epithelial cell transforming 2
|
|
EGFR
|
epidermal growth factor receptor
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
EWSR1
|
EWS RNA-binding protein 1
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
F2
|
coagulation factor II (thrombin)
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FGF23
|
fibroblast growth factor 23
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FLNA
|
filamin A, alpha
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FN1
|
fibronectin 1
|
|
FOXL1
|
forkhead box L1
|
|
FOXP1
|
forkhead box P1
|
|
FUS
|
FUS RNA binding protein
|
|
GALNT3
|
polypeptide N-acetylgalactosaminyltransferase 3
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GLUL
|
glutamate-ammonia ligase
|
|
GNAS
|
GNAS complex locus
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
|
GRN
|
granulin
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
HAVCR1
|
hepatitis A virus cellular receptor 1
|
|
HDAC1
|
histone deacetylase 1
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGB1
|
high mobility group box 1
|
|
HOXB9
|
homeobox B9
|
|
HPCAL1
|
hippocalcin-like 1
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
|
IDS
|
iduronate 2-sulfatase
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IL10
|
interleukin 10
|
|
IL17A
|
interleukin 17A
|
|
IL18
|
interleukin 18
|
|
IL18BP
|
interleukin 18 binding protein
|
|
IL18R1
|
interleukin 18 receptor 1
|
|
IL1B
|
interleukin 1, beta
|
|
IL33R
|
interleukin 33 receptor
|
|
IL6
|
interleukin 6
|
|
JAK2
|
Janus kinase 2
|
|
JAM3
|
junctional adhesion molecule 3
|
|
KCNJ10
|
potassium channel, inwardly rectifying subfamily J, member 10
|
|
KCNK3
|
potassium channel, two pore domain subfamily K, member 3
|
|
KDR
|
kinase insert domain receptor
|
|
KLK15
|
kallikrein-related peptidase 15
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LMX1B
|
LIM homeobox transcription factor 1, beta
|
|
LOC643387
|
TAR DNA binding protein pseudogene
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
MAML2
|
mastermind-like 2 (Drosophila)
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPT
|
microtubule-associated protein tau
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MED12
|
mediator complex subunit 12
|
|
MEFV
|
Mediterranean fever
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MGP
|
matrix Gla protein
|
|
MIR155
|
microRNA 155
|
|
MIR214
|
microRNA 214
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLPH
|
melanophilin
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MSLN
|
mesothelin
|
|
MTNR1A
|
melatonin receptor 1A
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC2
|
mucin 2, oligomeric mucus/gel-forming
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYH2
|
myosin, heavy chain 2, skeletal muscle, adult
|
|
MYH7
|
myosin, heavy chain 7, cardiac muscle, beta
|
|
MYOC
|
myocilin, trabecular meshwork inducible glucocorticoid response
|
|
MYOD1
|
myogenic differentiation 1
|
|
MYOT
|
myotilin
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NGFR
|
nerve growth factor receptor
|
|
NKX2-5
|
NK2 homeobox 5
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH3
|
notch 3
|
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NREP
|
neuronal regeneration related protein
|
|
OPTN
|
optineurin
|
|
OR51E2
|
olfactory receptor, family 51, subfamily E, member 2
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PAX2
|
paired box 2
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDPN
|
podoplanin
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PGR
|
progesterone receptor
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PLAC1
|
placenta-specific 1
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCI
|
protein kinase C, iota
|
|
PRNP
|
prion protein
|
|
PSEN1
|
presenilin 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTN
|
pleiotrophin
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTX3
|
pentraxin 3, long
|
|
RAB27A
|
RAB27A, member RAS oncogene family
|
|
RAP1A
|
RAP1A, member of RAS oncogene family
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RDH12
|
retinol dehydrogenase 12 (all-trans/9-cis/11-cis)
|
|
RECK
|
reversion-inducing-cysteine-rich protein with kazal motifs
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
|
RLN2
|
relaxin 2
|
|
ROBO3
|
roundabout, axon guidance receptor, homolog 3 (Drosophila)
|
|
ROBO4
|
roundabout, axon guidance receptor, homolog 4 (Drosophila)
|
|
RPGR
|
retinitis pigmentosa GTPase regulator
|
|
RPTOR
|
regulatory associated protein of MTOR, complex 1
|
|
RYR2
|
ryanodine receptor 2 (cardiac)
|
|
RYR3
|
ryanodine receptor 3
|
|
S1PR2
|
sphingosine-1-phosphate receptor 2
|
|
SELE
|
selectin E
|
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC4A11
|
solute carrier family 4, sodium borate transporter, member 11
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD3
|
SMAD family member 3
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNRNP70
|
small nuclear ribonucleoprotein 70kDa (U1)
|
|
SOAT2
|
sterol O-acyltransferase 2
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SPG11
|
spastic paraplegia 11 (autosomal recessive)
|
|
SPOP
|
speckle-type POZ protein
|
|
SRD5A2
|
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)
|
|
SST
|
somatostatin
|
|
TAC1
|
tachykinin, precursor 1
|
|
TARDBP
|
TAR DNA binding protein
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB2
|
transforming growth factor, beta 2
|
|
TGFB3
|
transforming growth factor, beta 3
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TGFBR3
|
transforming growth factor, beta receptor III
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TLR3
|
toll-like receptor 3
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF12A
|
tumor necrosis factor receptor superfamily, member 12A
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF12
|
tumor necrosis factor (ligand) superfamily, member 12
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TNKS2
|
tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase 2
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TREM1
|
triggering receptor expressed on myeloid cells 1
|
|
TRPA1
|
transient receptor potential cation channel, subfamily A, member 1
|
|
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8
|
|
TTR
|
transthyretin
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
TYMS
|
thymidylate synthetase
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
YWHAQ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
